DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Piper Sandler Reiterates Overweight on Ocular Therapeutix, Raises Price Target to $11

Piper Sandler analyst Joseph Catanzaro reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Overweight and raises the price target from $7 to $11.

Benzinga · 03/05/2020 13:35

Piper Sandler analyst Joseph Catanzaro reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Overweight and raises the price target from $7 to $11.